Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 20, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	92	228	115	288	167	116
Market Cap Growth	-36.09%	97.92%	-59.89%	72.07%	44.02%	-2.10%
Enterprise Value	133	268	167	336	218	175
Last Close Price	2.11	5.35	2.77	7.05	4.29	3.05
Forward PE	17.58	23.26	17.87	22.03	16.19	16.58
PS Ratio	0.93	2.03	1.02	2.42	1.64	1.00
PB Ratio	1.41	3.13	1.60	3.45	2.18	1.42
P/FCF Ratio	108.90	18.66	-	4294.24	20.44	17.00
P/OCF Ratio	22.90	16.28	100.17	227.98	17.92	14.43
PEG Ratio	1.03	1.03	1.03	1.03	1.03	1.03
EV/Sales Ratio	1.36	2.39	1.47	2.83	2.14	1.51
EV/EBITDA Ratio	46.27	28.27	70.15	29.72	22.08	17.85
EV/EBIT Ratio	-	107.55	-	91.12	96.86	84.46
EV/FCF Ratio	157.83	21.92	-	5018.20	26.69	25.63
Debt / Equity Ratio	0.70	0.59	0.75	0.68	0.75	0.80
Debt / EBITDA Ratio	9.15	3.69	12.09	4.24	4.79	5.56
Debt / FCF Ratio	54.34	3.49	-	850.15	7.04	9.53
Asset Turnover	0.72	0.79	0.74	0.75	0.64	0.70
Inventory Turnover	1.56	1.79	1.89	2.06	1.99	2.19
Quick Ratio	0.76	0.77	0.91	1.17	1.24	1.15
Current Ratio	2.06	1.85	2.20	2.43	2.46	2.12
Return on Equity (ROE)	-20.40%	-4.70%	-12.23%	-0.36%	-9.86%	-5.70%
Return on Assets (ROA)	-1.98%	1.10%	-2.11%	1.45%	0.88%	0.78%
Return on Capital (ROIC)	-2.32%	1.29%	-2.43%	1.68%	1.00%	0.89%
Earnings Yield	-15.48%	-1.50%	-8.25%	-0.10%	-4.67%	-4.04%
FCF Yield	0.92%	5.36%	-0.38%	0.02%	4.89%	5.88%
Buyback Yield / Dilution	-2.68%	-2.43%	-2.65%	-4.41%	-2.19%	-3.73%
Total Shareholder Return	-2.68%	-2.43%	-2.65%	-4.41%	-2.19%	-3.73%

Source: S&P Capital IQ. Standard template. Financial Sources.